References
- Gregory DG. New grading system and treatment guidelines for the acute ocular manifestations of Stevens‐Johnson syndrome. Ophthalmology 2016; 123: 1653–1658.
- Forrester JV, Dick AD, Mcmenamin PG et al. The Eye: Basic Sciences in Practice, 2nd ed. London: Saunders, 2003. pp. 355–356.
- Efron N, Efron S. Therapeutic applications (Chapter 29). In: Efron N, ed. Contact Lens Practice, 3rd ed. London: Elsevier, 2017; 278–279.
- Wall V, Yen MT, Yang MC et al. Management of the late ocular sequelae of Stevens‐Johnson syndrome. Ocul Surf 2003; 1: 192–201.
- Ciralsky JB, Sippel KC, Gregory DG. Current ophthalmologic treatment strategies for acute and chronic Stevens‐Johnson syndrome and toxic epidermal necrolysis. Curr Opin Ophthalmol 2013; 24: 321–328.
- Sall K, Stevenson OD, Mundorf TK et al. Two multicenter, randomized studies of the efficacy and safety of cyclosporine ophthalmic emulsion in moderate to severe dry eye disease. CsA Phase 3 Study Group. Ophthalmology 2000; 107: 631–639.
- Kaido M, Goto E, Dogru M et al. Punctal occlusion in the management of chronic Stevens‐Johnson syndrome. Ophthalmology 2004; 111: 895–900.
- Schornack MM, Pyle J, Patel SV. Scleral lenses in the management of ocular surface disease. Ophthalmology 2014; 121: 1398–1405.
- Downie LE, Lindsay RG. Contact lens management of keratoconus. Clin Exp Optom 2015; 98: 299–311.
- Michaud L, van der Worp E, Brazeau D et al. Predicting estimates of oxygen transmissibility for scleral lenses. Cont Lens Anterior Eye 2012; 35: 266–271.